for Injection 30 micrograms/ml.
Planipart Solution Presentation
Solution for injection. Each ml contains 30 micrograms clenbuterol hydrochloride and 10 mg benzyl alcohol as preservative.
To relax the uterus in cattle, usually at the time of parturition. In particular:
1.In heifers to delay delivery to allow full preparation of the soft birth canal.
2.As an aid to obstetrical manoeuvres in dystocia e.g. malpresentation and malposture.
3.To relax the uterus for caesarean section.
4.To delay and therefore programme delivery to permit observation of parturition e.g. avoidance of night time delivery.
5.To facilitate the replacement of prolapsed uterus.
6.In embryo transfer to ensure less traumatic manipulation of the uterus.
Dosage and administration
By slow intravenous injection. 10 ml per animal as a single injection.
The earlier in the stage of labour that treatment is given, the longer the period of delay of parturition. Once the cervix is fully dilated or the foetal feet are passing into the cervical area, Planipart will only delay parturition for a maximum of a few hours.
Contra-indications, warnings, etc
Known hypersensitivity to the active ingredient. Not to be used in conjunction with atropine. Not to be used with general anaesthesia because of a possible hypotensive effect. Antagonistic to the effects of prostaglandin F2-alpha and oxytocin.
Planipart is a beta-adrenergic stimulant and is therefore antagonised by beta-adrenergic blocking agents. In order to prevent additive effects, the product should not be given with other sympathomimetics or vasodilators. In case of accidental overdose, a beta-blocker such as propranolol may be used as an antidote.
Cattle must not be slaughtered for human consumption during treatment or until 14 days from the last treatment. Milk for human consumption must not be taken during treatment or within 60 hours from the last treatment.
When using do not eat, drink or smoke. After use, wash any contaminated skin immediately with soap and clean water. This product contains clenbuterol, a beta-agonist. Accidental self-injection may produce tachycardia and tremor. These effects may be reversed by the use of a non-selective beta-blocker. If accidental self-injection occurs seek medical advice immediately, avoiding driving if possible.
Clenbuterol decreases the tonus of the uterine muscles. Pregnant women should avoid any risk of exposure to Planipart and should not administer the product.
Unused product and containers should be disposed of in accordance with national requirements.
Protect from light. Do not store above 25°C. Following withdrawal of the first dose use the product within 28 days. Discard unused material.
Avoid the introduction of contamination during use. Should any apparent growth or discolouration occur, the product should be discarded.
Keep out of the reach and sight of children.
POM-V CD(Sch 4 Pt 2)
Amber vials containing 50 ml of solution.